Cefaclor

Product NDC
63629-1007
Requested package NDC
63629-1007-3
11-digit product format
636291007
Labeler code
63629
Product ID
63629-1007_42d6e553-875b-4c77-a161-3bb02c1f23b8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cefaclor
Dosage form
CAPSULE
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA065146
Marketing category
ANDA
Marketing start
2008-07-31
Marketing end
0000-00-00
Substance
CEFACLOR
Active strength
250 mg/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63629-100763629-1007-3DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A065146-001CEFACLORCEFACLOREQ 250MG BASECAPSULE / ORAL2004-01-22
A065146-002CEFACLORCEFACLOREQ 500MG BASECAPSULE / ORALRS2004-01-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A065146-001CEFACLOREQ 250MG BASECAPSULE / ORAL2004-01-22a50c72e98297…
2026-08-01 22:54:322026-06A065146-002CEFACLOREQ 500MG BASECAPSULE / ORALRS2004-01-22a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefaclorCEFACLORCarlsbad Technology, Inc.2f61354e-bcb0-41aa-955f-51eabc11387b2025-05-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065146
application number: ANDA065146
CefaclorCEFACLORA-S Medication Solutionsd79a4b28-ef2b-4f0f-baec-002df7d06dd42024-01-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 065146
application number: ANDA065146

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63629-1007-36362910070330 CAPSULE in 1 BOTTLE (63629-1007-3) 30 capsule2022-04-140000-00-00NoNoCurrent